Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Single-Blind, Endoscopic Evaluation Of Upper GI Mucosal Damage Induced By PL-2200 Versus Aspirin In Healthy Volunteers

NCT00872534 is registered in ClinicalTrials.gov with PLx Pharma as lead sponsor.

NCT NCT00872534
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00872534 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Single-Blind, Endoscopic Evaluation Of Upper GI Mucosal Damage Induced By PL-2200 Versus Aspirin In Healthy Volunteers
Lead sponsor
PLx Pharma
Phase
Phase 1/2
Overall status
Completed
Start date
January 31, 2009
Completion date
July 31, 2009
Enrollment
204 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

upper gastrointestinal mucosal damage